Sign in
4

Changes in Ownership

Chemomab Therapeutics Ltd. Filed Acc 0001178913-26-004371

Director sold 2,304 shares at an average $2.83 ($6,516)

From the SEC's structured data for this filing

Trades in this filing

Cohen Neil Harris · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-27 Sale : show line 1 in the form −1,304 $2.85 $3,716 34,000 D
2026-08-28 Sale : show line 2 in the form −1,000 $2.80 $2,800 33,000 D
Open-market sales · 2,304 sh · avg $2.83 · $6,516

Table II: Derivative

7 lines
Date Transaction Shares Owned after D/I
2020-07-16 Grant or award : show line 3 in the form Stock option (right to buy American Depositary Shares) +172 172 D
2021-04-19 Grant or award : show line 4 in the form Stock option (right to buy American Depositary Shares) +2,971 3,143 D
2022-03-07 Grant or award : show line 5 in the form Stock option (right to buy American Depositary Shares) +1,705 4,848 D
2023-03-21 Grant or award : show line 6 in the form Stock option (right to buy American Depositary Shares) +1,714 6,562 D
2024-03-18 Grant or award : show line 7 in the form Stock option (right to buy American Depositary Shares) +2,520 9,082 D
2025-03-16 Grant or award : show line 8 in the form Stock option (right to buy American Depositary Shares) +3,821 12,903 D
2026-03-16 Grant or award : show line 9 in the form Stock option (right to buy American Depositary Shares) +5,172 18,075 D
Loading xslF345X06/ownership.xml…